Showing results (51-60 of 127) with videos related to
Sort By:
Pageof 13
Cancer Investigation|May 15, 2003
Combination chemotherapy with gemcitabine and vinorelbine in the treatment of patients with relapsed or refractory small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research NetworkJohn D Hainsworth, Howard A Burris, Joan B Erland, et al.Cancer|January 15, 2008
Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research NetworkJohn D Hainsworth, Elizabeth R Vazquez, David R Spigel, et al.Cancer|March 17, 2009
Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neckJohn D Hainsworth, David R Spigel, Howard A Burris, et al.Cancer|September 1, 2005
Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site: a Minnie Pearl Cancer Research Network Phase II trialJohn D Hainsworth, David R Spigel, Eric L Raefsky, et al.Cancer Investigation|April 26, 2013
Sorafenib and everolimus in advanced clear cell renal carcinoma: a phase I/II trial of the SCRI Oncology Research ConsortiumJohn D Hainsworth, David M Waterhouse, William C Penley, et al.Cancer Investigation|August 2, 2017
First-Line Carboplatin, Pemetrexed, and Panitumumab in Patients with Advanced Non-Squamous KRAS Wild Type (WT) Non-Small-Cell Lung Cancer (NSCLC)David R Spigel, Tarek M Mekhail, David Waterhouse, et al.The Oncologist|August 28, 2010
A phase I study of weekly topotecan in combination with pemetrexed in patients with advanced malignanciesHoward A Burris, Jeffrey R Infante, Roxanne C Jewell, et al.Cancer|November 6, 2003
Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trialAnthony A Meluch, F Anthony Greco, Lisa H Morrissey, et al.Oncogene|July 10, 2025
Salvage therapy with allogeneic invariant natural killer cells in a heavily pre-treated germ cell tumorBenjamin Garmezy, Joseph E Grossman, Jennifer Buell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Rituximab as first-line and maintenance therapy for patients with indolent non-hodgkin's lymphomaJohn D Hainsworth, Sharlene Litchy, Howard A Burris, et al.Pageof 13